Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.
- How Early Manufacturing Decisions Shape Long-Term Success
- Here's A Thought: What If Gene Editing Didn't Use Bacterial Enzymes?
- Analyzing CAR-T Surface Proteins With Immunoprecipitation Coupled With Mass Spectrometry
- Regulatory Pathways — With Real-Life Examples — For Successful CGT Clinical Trials
- Program Manager Alignment And Integration: Best Practices When Working With A CDMO
- New Guide Aims To Build Robust Framework For Digital Validation Tools
- Pfizer's Accord For A Healthier World Program Challenges Stability Study Norms
- The 9 Fastest-Growing Outsourcing Segments
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Streamlining Compliance With Pre-Clinical Safety Tests
As cell therapies advance, challenges in ensuring safe, scalable, and compliant production increase. Discover how to develop efficient strategies to maintain cell viability and functionality throughout the supply chain.
-
Monitoring Microbial Contamination Of Mammalian Cell Cultures
Mammalian cells are widely used to produce complex processed molecules. Explore a system that effectively detects microbial contamination in mammalian cell cultures and utilizes a newly formulated lysis buffer.
-
Studying The Spatial Architecture Of Glioblastoma
Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).
-
In-line, Raman-Based PAT Solution For Monitoring And Control
With an in-line, Raman-based PAT solution you can monitor and control several critical process parameters (CPP) to maintain optimal cell culture conditions.
-
Optimized Urine Liquid Biopsy Workflow
Urine-derived cell-free DNA is revolutionizing liquid biopsy research to offer a non-invasive, accessible tool for early disease detection, monitoring, and comprehensive diagnostics across oncology.
-
Media And Buffer Mixing Using The Xcellerex™ Magnetic Mixer
A common requirement for media and buffer preparation in biopharma processing is powder-liquid mixing. Review the performance of a 3000 L single-use mixing system for preparing aqueous solutions.
-
Automated Testing For Compound Toxicity Effects
Explore how anti-cancer drugs' toxic effects on intestinal cells limit dosages as well as how 3D organoids and assay automation can enhance drug development by improving testing processes.
-
Rapid, Automated, At-Line Adenovirus Quantitation
Gain insight into how a high-throughput capsid assay for rapid AV quantification was developed using an innovative Bio-Layer Interferometry (BLI) platform that offers high precision and reliability.
-
Real-Time Monitoring Of Key Bioprocess Parameters
The success of this experiment shows how the integration of Process Analytical Technology probes into bioreactors can enhance process understanding and enable precise bioprocess monitoring and control.
-
Improving Methodologies For iPSC Manufacturing And Differentiation
Learn how next-generation workflows are being developed to streamline iPSC manufacturing, enhance differentiation strategies, and overcome the hurdles of scalability and consistency.
NEWSLETTER ARCHIVE
- How Early Manufacturing Decisions Shape Long-Term Success
- Understanding CLL And SLL Treatment Evolution
- Advancing Telomere Targeting Therapy For Non-Small Cell Lung Cancer
- BlueRock Advances Cell Therapy For Parkinson's Disease
- Driving Prostate Cancer Innovation Through Immunotherapy With OS Therapies' Dr. Robert Petit
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections